Involvement of PARK2-mediated mitophagy in idiopathic pulmonary fibrosis pathogenesis

Journal of Immunology

Volumn 197, Issue 2, 2016, Pages 504-516

  Kobayashi, Kenji ^a   Araya, Jun ^a   Minagawa, Shunsuke ^a   Hara, Hiromichi ^a   Saito, Nayuta ^a   Kadota, Tsukasa ^a   Sato, Nahoko ^a   Yoshida, Masahiro ^a   Tsubouchi, Kazuya ^a   Kurita, Yusuke ^a   Ito, Saburo ^a   Fujita, Yu ^a   Takasaka, Naoki ^a   Utsumi, Hirofumi ^a   Yanagisawa, Haruhiko ^a   Hashimoto, Mitsuo ^a   Wakui, Hiroshi ^a   Kojima, Jun ^a   Shimizu, Kenichiro ^a   Numata, Takanori ^a   Kawaishi, Makoto ^a   Kaneko, Yumi ^a   Asano, Hisatoshi ^a   Yamashita, Makoto ^a   Odaka, Makoto ^a   Morikawa, Toshiaki ^a   Nakayama, Katsutoshi ^a   Kuwano, Kazuyoshi ^a   more..

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DIMETHOXY 2 PHENYLQUINOXALINE; BLEOMYCIN; PARK2 PROTEIN; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; UNCLASSIFIED DRUG; PARKIN; UBIQUITIN PROTEIN LIGASE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MITOPHAGY; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIAL DEGRADATION; MYOFIBROBLASTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84978160721     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600265     Document Type: Article

References (37)

1. Raghu, G., H. R. Collard, J. J. Egan, F. J. Martinez, J. Behr, K. K. Brown, T. V. Colby, J. F. Cordier, K. R. Flaherty, J. A. Lasky, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. 2011. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183: 788-824.
2. Selman, M., and A. Pardo. 2014. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model. Am. J. Respir. Crit. Care Med. 189: 1161-1172.
3. Araya, J., and S. L. Nishimura. 2010. Fibrogenic reactions in lung disease. Annu. Rev. Pathol. 5: 77-98.
4. King, T. E., Jr., A. Pardo, and M. Selman. 2011. Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961.
5. Hung, C., G. Linn, Y. H. Chow, A. Kobayashi, K. Mittelsteadt, W. A. Altemeier, S. A. Gharib, L. M. Schnapp, and J. S. Duffield. 2013. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188: 820-830.
6. Araya, J., H. Hara, and K. Kuwano. 2013. Autophagy in the pathogenesis of pulmonary disease. Intern. Med. 52: 2295-2303.
7. Kroemer, G., G. Mariño, and B. Levine. 2010. Autophagy and the integrated stress response. Mol. Cell 40: 280-293.
8. Araya, J., J. Kojima, N. Takasaka, S. Ito, S. Fujii, H. Hara, H. Yanagisawa, K. Kobayashi, C. Tsurushige, M. Kawaishi, et al. 2013. Insufficient autophagy in idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 304: L56-L69.
9. Nakatogawa, H., K. Suzuki, Y. Kamada, and Y. Ohsumi. 2009. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 10: 458-467.
10. Siani, A., and N. Tirelli. 2014. Myofibroblast differentiation: main features, biomedical relevance, and the role of reactive oxygen species. Antioxid. Redox Signal. 21: 768-785.
11. Lei, H., and A. Kazlauskas. 2014. A reactive oxygen species-mediated, selfperpetuating loop persistently activates platelet-derived growth factor receptor a. Mol. Cell. Biol. 34: 110-122.
12. Homma, S., I. Nagaoka, H. Abe, K. Takahashi, K. Seyama, T. Nukiwa, and S. Kira. 1995. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am. J. Respir. Crit. Care Med. 152: 2084-2089.
13. Aono, Y., Y. Nishioka, M. Inayama, M. Ugai, J. Kishi, H. Uehara, K. Izumi, and S. Sone. 2005. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 171: 1279-1285.
14. Smith, C. L., S. T. Baek, C. Y. Sung, and M. D. Tallquist. 2011. Epicardialderived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 108: e15-e26.
15. Chen, Y. T., F. C. Chang, C. F.Wu, Y. H. Chou, H. L. Hsu,W. C. Chiang, J. Shen, Y. M. Chen, K. D. Wu, T. J. Tsai, et al. 2011. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 80: 1170-1181.
16. Corti, O., and A. Brice. 2013. Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr. Opin. Neurobiol. 23: 100-108.
17. Mizumura, K., S. M. Cloonan, K. Nakahira, A. R. Bhashyam, M. Cervo, T. Kitada, K. Glass, C. A. Owen, A. Mahmood, G. R. Washko, et al. 2014. Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD. J. Clin. Invest. 124: 3987-4003.
18. Bueno, M., Y. C. Lai, Y. Romero, J. Brands, C. M. St Croix, C. Kamga, C. Corey, J. D. Herazo-Maya, J. Sembrat, J. S. Lee, et al. 2015. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J. Clin. Invest. 125: 521-538.
19. Ito, S., J. Araya, Y. Kurita, K. Kobayashi, N. Takasaka, M. Yoshida, H. Hara, S. Minagawa, H. Wakui, S. Fujii, et al. 2015. PARK2-mediated mitophagy is involved in regulation of HBEC senescence in COPD pathogenesis. Autophagy 11: 547-559.
20. Araya, J., S. Cambier, J. A. Markovics, P. Wolters, D. Jablons, A. Hill, W. Finkbeiner, K. Jones, V. C. Broaddus, D. Sheppard, et al. 2007. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J. Clin. Invest. 117: 3551-3562.
21. Kabeya, Y., N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi, and T. Yoshimori. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19: 5720-5728.
22. Frijhoff, J., M. Dagnell, M. Augsten, E. Beltrami, M. Giorgio, and A. Ö stman. 2014. The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation. Free Radic. Biol. Med. 68: 268-277.
23. Conte, E., M. Fruciano, E. Fagone, E. Gili, F. Caraci, M. Iemmolo, N. Crimi, and C. Vancheri. 2011. Inhibition of PI3K prevents the proliferation and differentiation of human lung fibroblasts into myofibroblasts: the role of class I p110 isoforms. PLoS One 6: e24663.
24. Zhang, Y., and J. H. Yang. 2013. Activation of the PI3K/Akt pathway by oxidative stress mediates high glucose-induced increase of adipogenic differentiation in primary rat osteoblasts. J. Cell. Biochem. 114: 2595-2602.
25. Geisler, S., K. M. Holmström, D. Skujat, F. C. Fiesel, O. C. Rothfuss, P. J. Kahle, and W. Springer. 2010. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12: 119-131.
26. Hara, H., J. Araya, S. Ito, K. Kobayashi, N. Takasaka, Y. Yoshii, H. Wakui, J. Kojima, K. Shimizu, T. Numata, et al. 2013. Mitochondrial fragmentation in cigarette smoke-induced bronchial epithelial cell senescence. Am. J. Physiol. Lung Cell. Mol. Physiol. 305: L737-L746.
27. Passos, J. F., and Tv. Zglinicki. 2012. Mitochondrial dysfunction and cell senescence-skin deep into mammalian aging. Aging (Albany, NY) 4: 74-75.
28. Rubinsztein, D. C., G. Mariño, and G. Kroemer. 2011. Autophagy and aging. Cell 146: 682-695.
29. LeBleu, V. S., and R. Kalluri. 2011. Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int. 80: 1119-1121.
30. Hostettler, K. E., J. Zhong, E. Papakonstantinou, G. Karakiulakis, M. Tamm, P. Seidel, Q. Sun, J. Mandal, D. Lardinois, C. Lambers, and M. Roth. 2014. Antifibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis. Respir. Res. 15: 157.
31. Noskovicova, N., M. Petrek, O. Eickelberg, and K. Heinzelmann. 2015. Plateletderived growth factor signaling in the lung. From lung development and disease to clinical studies. Am. J. Respir. Cell Mol. Biol. 52: 263-284.
32. Richeldi, L., R. M. du Bois, G. Raghu, A. Azuma, K. K. Brown, U. Costabel, V. Cottin, K. R. Flaherty, D. M. Hansell, Y. Inoue, et al; INPULSIS Trial Investigators. 2014. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 370: 2071-2082.
33. Sampson, N., P. Berger, and C. Zenzmaier. 2012. Therapeutic targeting of redox signaling in myofibroblast differentiation and age-related fibrotic disease. Oxid. Med. Cell. Longev. 2012: 458276.
34. Otera, H., and K. Mihara. 2011. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 149: 241-251.
35. Bernard, K., N. J. Logsdon, S. Ravi, N. Xie, B. P. Persons, S. Rangarajan, J. W. Zmijewski, K. Mitra, G. Liu, V. M. Darley-Usmar, and V. J. Thannickal. 2015. Metabolic reprogramming is required for myofibroblast contractility and differentiation. J. Biol. Chem. 290: 25427-25438.
36. Park, J., S. B. Lee, S. Lee, Y. Kim, S. Song, S. Kim, E. Bae, J. Kim, M. Shong, J. M. Kim, and J. Chung. 2006. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441: 1157-1161.
37. Noble, P. W., and R. J. Homer. 2004. Idiopathic pulmonary fibrosis: new insights into pathogenesis. Clin. Chest Med. 25: 749-758.